Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Epac1-/- mice have elevated baseline permeability and do not respond to histamine as measured with dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.

Curry FE, Taxt T, Rygh CB, Pavlin T, Bjønrstad R, Døskeland SO, Reed RK.

Acta Physiol (Oxf). 2019 Mar;225(3):e13199. doi: 10.1111/apha.13199. Epub 2018 Nov 2.

2.

Semi-parametric arterial input functions for quantitative dynamic contrast enhanced magnetic resonance imaging in mice.

Taxt T, Reed RK, Pavlin T, Rygh CB, Andersen E, Jiřík R.

Magn Reson Imaging. 2018 Feb;46:10-20. doi: 10.1016/j.mri.2017.10.004. Epub 2017 Oct 21.

PMID:
29066294
3.

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.

Zhu H, Leiss L, Yang N, Rygh CB, Mitra SS, Cheshier SH, Weissman IL, Huang B, Miletic H, Bjerkvig R, Enger PØ, Li X, Wang J.

Oncotarget. 2017 Feb 14;8(7):12145-12157. doi: 10.18632/oncotarget.14553.

4.

Increased microvascular permeability in mice lacking Epac1 (Rapgef3).

Kopperud RK, Rygh CB, Karlsen TV, Krakstad C, Kleppe R, Hoivik EA, Bakke M, Tenstad O, Selheim F, Lidén Å, Madsen L, Pavlin T, Taxt T, Kristiansen K, Curry FE, Reed RK, Døskeland SO.

Acta Physiol (Oxf). 2017 Feb;219(2):441-452. doi: 10.1111/apha.12697. Epub 2016 May 17.

5.

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT (18F-Fluoromisonidazole & 18F-Fluorocholine) and DCE-US.

Arteaga-Marrero N, Rygh CB, Mainou-Gomez JF, Adamsen TC, Lutay N, Reed RK, Olsen DR.

J Transl Med. 2016 Feb 24;14:59. doi: 10.1186/s12967-016-0813-0. No abstract available.

6.

Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.

Haldorsen IS, Popa M, Fonnes T, Brekke N, Kopperud R, Visser NC, Rygh CB, Pavlin T, Salvesen HB, McCormack E, Krakstad C.

PLoS One. 2015 Aug 7;10(8):e0135220. doi: 10.1371/journal.pone.0135220. eCollection 2015.

7.

Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts.

Arteaga-Marrero N, Rygh CB, Mainou-Gomez JF, Nylund K, Roehrich D, Heggdal J, Matulaniec P, Gilja OH, Reed RK, Svensson L, Lutay N, Olsen DR.

Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):428-37. doi: 10.1002/cmmi.1645. Epub 2015 May 26.

PMID:
26010530
8.

Melanoma brain metastasis is independent of lactate dehydrogenase A expression.

Sundstrøm T, Espedal H, Harter PN, Fasmer KE, Skaftnesmo KO, Horn S, Hodneland E, Mittelbronn M, Weide B, Beschorner R, Bender B, Rygh CB, Lund-Johansen M, Bjerkvig R, Thorsen F.

Neuro Oncol. 2015 Oct;17(10):1374-85. doi: 10.1093/neuonc/nov040. Epub 2015 Mar 19.

9.

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.

Fack F, Espedal H, Keunen O, Golebiewska A, Obad N, Harter PN, Mittelbronn M, Bähr O, Weyerbrock A, Stuhr L, Miletic H, Sakariassen PØ, Stieber D, Rygh CB, Lund-Johansen M, Zheng L, Gottlieb E, Niclou SP, Bjerkvig R.

Acta Neuropathol. 2015 Jan;129(1):115-31. doi: 10.1007/s00401-014-1352-5. Epub 2014 Oct 17.

10.

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma.

Rygh CB, Wang J, Thuen M, Gras Navarro A, Huuse EM, Thorsen F, Poli A, Zimmer J, Haraldseth O, Lie SA, Enger PØ, Chekenya M.

PLoS One. 2014 Sep 30;9(9):e108414. doi: 10.1371/journal.pone.0108414. eCollection 2014.

11.

Image-based assessment of microvascular function and structure in collagen XV- and XVIII-deficient mice.

Rygh CB, Løkka G, Heljasvaara R, Taxt T, Pavlin T, Sormunen R, Pihlajaniemi T, Curry FR, Tenstad O, Reed RK.

J Physiol. 2014 Jan 15;592(2):325-36. doi: 10.1113/jphysiol.2013.263574. Epub 2013 Nov 11.

12.

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.

Poli A, Wang J, Domingues O, Planagumà J, Yan T, Rygh CB, Skaftnesmo KO, Thorsen F, McCormack E, Hentges F, Pedersen PH, Zimmer J, Enger PØ, Chekenya M.

Oncotarget. 2013 Sep;4(9):1527-46.

13.

Single-channel blind estimation of arterial input function and tissue impulse response in DCE-MRI.

Taxt T, Jirík R, Rygh CB, Grüner R, Bartos M, Andersen E, Curry FR, Reed RK.

IEEE Trans Biomed Eng. 2012 Apr;59(4):1012-21. doi: 10.1109/TBME.2011.2182195. Epub 2011 Dec 30.

PMID:
22217906
14.

Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.

Wang J, Svendsen A, Kmiecik J, Immervoll H, Skaftnesmo KO, Planagumà J, Reed RK, Bjerkvig R, Miletic H, Enger PØ, Rygh CB, Chekenya M.

PLoS One. 2011;6(7):e23062. doi: 10.1371/journal.pone.0023062. Epub 2011 Jul 29.

15.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.

Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54. doi: 10.1073/pnas.1014480108. Epub 2011 Feb 14.

16.

Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET.

Rygh CB, Qin S, Seo JW, Mahakian LM, Zhang H, Adamson R, Chen JQ, Borowsky AD, Cardiff RD, Reed RK, Curry FR, Ferrara KW.

Clin Cancer Res. 2011 Feb 1;17(3):550-9. doi: 10.1158/1078-0432.CCR-10-2049. Epub 2010 Nov 24.

17.

Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.

Curry FR, Rygh CB, Karlsen T, Wiig H, Adamson RH, Clark JF, Lin YC, Gassner B, Thorsen F, Moen I, Tenstad O, Kuhn M, Reed RK.

J Physiol. 2010 Jan 15;588(Pt 2):325-39. doi: 10.1113/jphysiol.2009.180463. Epub 2009 Nov 30.

Supplemental Content

Support Center